Diagnosis, Treatment, and Follow‐Up of Borderline Ovarian Tumors
نویسندگان
چکیده
منابع مشابه
Diagnosis, treatment, and follow-up of borderline ovarian tumors.
Borderline ovarian tumors represent a heterogeneous group of noninvasive tumors of uncertain malignant potential with characteristic histology. They occur in younger women, are present at an early stage, and have a favorable prognosis, but symptomatic recurrence and death may be found as long as 20 years after therapy in some patients. The molecular changes in borderline ovarian tumors indicate...
متن کاملBorderline ovarian tumors: a review of treatment.
Borderline ovarian tumors have an excellent prognosis. In stage I disease, no therapy in addition to surgery is needed, and conservation of ovarian tissue for future childbearing may be appropriate. In advanced stages, the use of adjuvant therapy has not consistently led to cures, and complications have been reported. A randomized study of no adjuvant therapy versus adjuvant treatment with long...
متن کاملRecurrence of borderline ovarian tumors.
AIM To increase the efficiency of diagnosis and treatment of patients with recurrences of borderline ovarian tumors (BOT). MATERIALS AND METHODS 106 patients with BOT of stage I have been treated and clinically observed: the I group (82 patients, mean age -- 38.9 ± 5.5 years), who were treated with standard surgical operation (panhysterectomy); the II group (24 patients, mean age -- 30.3 ± 5....
متن کاملControversies in borderline ovarian tumors
Borderline ovarian tumors (BOTs) represent about 15% to 20% of all ovarian malignancies and differ from invasive ovarian cancers (IOCs) by many characters. Historically, standard management of BOT is peritoneal washing cytology, hysterectomy, bilateral salpingo-oophorectomy, omentectomy, complete peritoneal resection of macroscopic lesions; in case of mucinous BOTs, appendectomy should be perfo...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Oncologist
سال: 2012
ISSN: 1083-7159,1549-490X
DOI: 10.1634/theoncologist.2012-0139